Background
Methods
Study design
Survey questionnaire
Analytic methods
Results
Demographics characteristics of PCPs surveyed in 2011 and 2014
Years | 2011 N = 364 (%) | 2014 N = 293 (%) |
P value | CFPS 2011a
N = 1400 (%) |
---|---|---|---|---|
Gender | ||||
Male | 223 (61.3) | 157 (53.6) |
0.046
| (60) |
D.N.P. | 3 (0.8) | 1 (0.3) | ||
Age | ||||
21–40 years | 111 (30.5) | 82 (28.0) | (58) for <45 yrs | |
41–60 years | 185 (50.8) | 185 (63.1) | ||
61 years or above | 67 (18.4) | 26 (8.9) |
<0.001
| (42) for ≥45 yrs |
D.N.P. | 1 (0.3) | 0 | ||
Highest Qualifications | ||||
M.B.,B.S. (or equivalent) only | 231 (63.5) | 133 (45.4) | N.A. | |
Post-graduate degrees | 124 (34.1) | 158 (53.9) |
<0.001
| N.A. |
D.N.P. | 9 (2.4) | 2 (0.7) | ||
Practice | ||||
Private | 253 (69.5) | 206 (70.3) | (55.9) | |
Polyclinic | 105 (28.8) | 87 (29.7) | 0.931 | (44.1) |
D.N.P. | 6 (1.7) | 0 |
Knowledge on dengue warning signs and clinical management
Overall |
P value | Private practice |
P value | Polyclinic practice |
P value | ||||
---|---|---|---|---|---|---|---|---|---|
2011 N = 364 (%) | 2014 N = 293 (%) | 2011 N = 253 (%) | 2014 N = 206 (%) | 2011 N = 105 (%) | 2014 N = 87 (%) | ||||
WHO warning signs | |||||||||
Yes | 285 (78.3) | 250 (85.3) |
0.024
| N.A. | 171 (83.4) | N.A. | N.A. | 79 (91.9) | N.A. |
D.N.P. | 3 (0.8) | 2 (0.7) | 2 (1) | 1 (1.1) | |||||
Dengue Diagnostic Test (DDT) | |||||||||
Always (100%) | 107 (29.4) | 164 (56.0) |
<0.001
| 98 (38.7) | 111 (53.9) |
0.001
| 7 (6.7) | 53 (60.9) |
<0.001
|
Often (51–99%) | 69 (19.0) | 72 (24.5) | 0.086 | 51 (20.2) | 52 (25.2) | 0.216 | 17 (16.2) | 20 (23.0) | 0.274 |
Sometimes (1–50%) | 105 (28.8) | 40 (13.7) |
<0.001
| 61 (24.1) | 26 (12.6) |
0.002
| 41 (39) | 14 (16.1) |
<0.001
|
Never (0%) | 82 (22.5) | 17 (5.8) |
<0.001
| 43 (17.0) | 17 (8.3) |
0.008
| 39 (37.1) | 0 |
<0.001
|
D.N.P. | 1 (0.3) | 0 | 0 | 0 | 1 (1) | 0 | |||
Dengue Diagnostic Test (DDT) | |||||||||
> 50% of the time | 176 (48.4) | 236 (80.5) |
<0.001
| 149 (58.9) | 163 (79.1) |
<0.001
| 24 (22.9) | 73 (83.9) |
<0.001
|
D.N.P. | 1 (0.3) | 0 | 0 | 0 | 1 (1) | 0 | |||
Most Frequently Used DDT Among Those Who Reported Usage of DDT | |||||||||
Dengue serology (IgM/IgG) | 211 (74.8) | 91 (33) |
<0.001
| 144 (68.6) | 59 (31.2) |
<0.001
| 62 (93.9) | 32 (36.8) |
<0.001
|
Dengue non-structural antigen 1 (NS1) assay | 31 (11) | 62 (22.5) |
<0.001
| 29 (13.8) | 47 (24.9) |
0.003
| 1 (1.5) | 15 (17.2) |
0.002
|
Dengue RT-PCR | 37 (13.1) | 9 (3.3) |
<0.001
| 36 (17.1) | 7 (3.7) |
<0.001
| 1 (1.5) | 2 (2.3) | >0.999 |
Dengue duo POCT kit | 0 (0.0) | 104 (37.7) |
<0.001
| 0 | 67 (35.4) |
<0.001
| 0 | 37 (42.5) |
<0.001
|
D.N.P. | 3 (1.1) | 10 (3.5) | 1 (0.5) | 9 (4.8) | 2 (3) | 1 (1.2) |
Attitude and practices on dengue diagnostic tests
Variables in equation | Adjusted Odds Ratio (95% confidence interval) |
P value |
---|---|---|
Type of Dengue diagnostic test | ||
Other tests | Referent | |
Dengue duo POCT kit |
2.15 (1.25–3.69)
|
0.01
|
Gender | ||
Male | Referent | |
Female | 1.16 (0.69–1.96) | 0.57 |
Age | ||
21–40 years | Referent | |
41–60 years | 0.71 (0.38–1.32) | 0.27 |
61 years or above | 0.72 (0.24–2.14) | 0.56 |
Place of practice | ||
Private | Referent | |
Polyclinic | 0.79 (0.42–1.46) | 0.45 |
Qualifications | ||
M.B.,B.S. (or equivalent) | Referent | |
GDFM | 1.05 (0.56–1.95) | 0.88 |
M.Med (Fam. Med.) | 1.08 (0.56–2.10) | 0.81 |
MRCP | 2.81 (0.30–26.62) | 0.37 |
Clinical care and practices for dengue
Overall |
P value | Private practice |
P value | Polyclinic practice |
P value | ||||
---|---|---|---|---|---|---|---|---|---|
2011
N = 364 (%) | 2014
N = 293 (%) | 2011
N = 253 (%) | 2014
N = 206 (%) | 2011
N = 105 (%) | 2014
N = 87 (%) | ||||
Referral to hospital | |||||||||
> 50% | 114 (31.4) | 39 (13.3) |
<0.001
| 99 (39.1) | 36 (17.5) |
<0.001
| 14 (13.3) | 3 (3.4) |
0.020
|
D.N.P. | 1 (0.3) | 0 | 1 (0.4) | 0 | 0 | 0 | |||
Usage of platelet count | |||||||||
≤ 100,000/mm3 | 88 (24.2) | 30 (10.2) |
<0.001
| 79 (31.2) | 29 (14.1) |
<0.001
| 8 (7.6) | 1 (1.1) |
0.042
|
≤ 80,000/mm3 | 190 (52.2) | 133 (45.4) | 0.085 | 117 (46.2) | 101 (49.0) | 0.574 | 70 (66.7) | 32 (36.8) |
<0.001
|
≤ 50,000/mm3 | 83 (22.8) | 115 (39.2) |
<0.001
| 54 (21.3) | 66 (32.0) |
0.010
| 27 (25.7) | 49 (56.3) |
<0.001
|
Platelet count is not an indicator | 3 (0.8) | 15 (5.1) |
0.001
| 3 (1.2) | 10 (4.9) | 0.230 | 0 (0.0) | 5 (5.7) |
0.018
|
Average number of clinical review per patient | |||||||||
1–2 | 64 (17.6) | 29 (9.9) |
0.005
| 49 (19.4) | 20 (9.7) |
0.004
| 14 (13.3) | 9 (10.3) | 0.656 |
3–4 | 217 (59.6) | 171 (58.4) | 0.688 | 140 (55.3) | 118 (57.3) | 0.775 | 74 (70.5) | 53 (61) | 0.172 |
5–6 | 66 (18.1) | 83 (28.3) |
0.003
| 48 (19) | 59 (28.6) |
0.020
| 16 (15.2) | 24 (27.6) |
0.049
|
> 6 | 12 (3.3) | 8 (2.7) | 0.820 | 11 (4.3) | 7 (3.4) | 0.637 | 1 (1) | 1 (1.1) | 1.000 |
D.N.P. | 5 (1.4) | 2 (0.7) | 5 (2) | 2 (1) | 0 | 0 | |||
Fluid Intake/Urine Output Test | |||||||||
> 50% of the time | 208 (57.1) | 172 (58.7) | 0.751 | 142 (56.1) | 113 (54.9) | 0.777 | 61 (58.1) | 59 (67.8) |
<0.001
|
D.N.P. | 1 (0.3) | 0 | 0 | 0 | 1 (1) | 0 | |||
Use of postural blood pressure | |||||||||
> 50% of the time | 179 (49.2) | 121 (41.3) |
0.049
| 126 (49.8) | 82 (39.8) |
0.038
| 61 (58.1) | 59 (67.8) |
<0.001
|
Knowledge, attitude and experience toward POCT kits
N (%) | |
---|---|
Heard about point of care rapid Dengue test | |
Yes | 202 (68.9) |
No, Not sure | 89 (30.4) |
D.N.P. | 2 (0.7) |
Wish to know more about point of care rapid Dengue test | |
Yes | 258 (88.1) |
No | 31 (10.6) |
D.N.P. | 4 (1.3) |
Preferred mode of informationa
| |
Postal written information | 76 (31.5) |
Website with video | 70 (29.0) |
Email and written demonstration | 68 (28.2) |
Seminar through demo | 41 (17.0) |
Public posters | 8 (3.3) |
Other | 4 (1.7) |
N (%) | |
---|---|
Usage of point of care rapid dengue test in clinic among PCPs who knows about it (N = 202) | |
Yes | 41 (20.3) |
No | 157 (77.7) |
D.N.P. | 4 (2) |
Duration of using point of care rapid dengue test (N = 41) | |
< 1 month | 4 (9.8) |
1–3 months | 3 (7.2) |
> 3 months | 30 (73.2) |
D.N.P. | 4 (9.8) |
Benefits perceived by PCPs in using POCT in their clinica
| |
Saves waiting time | 203 (84.2) |
Helps case management | 195 (80.9) |
More accurate diagnosis | 137 (56.8) |
Minimum usage of resources | 91 (37.8) |
Manage surge in Dengue | 87 (36.1) |
Don’t know about it | 44 (18.3) |
Others (benefits) | 8 (3.3) |
Challenges perceived by PCPs in using POCT in their clinica
| |
Not cost effective | 61 (25.3) |
Too much workload | 41 (17.0) |
Too much time for training | 32 (13.3) |
Not accurate | 27 (11.2) |
No challenges | 26 (10.) |
No comment | 1 (0.4) |
Others (Challenges) | 49 (20.3) |
Themes | Frequency | Quotes |
---|---|---|
Positive | ||
Can be used to diagnose in both early and late phase of fever | 36 |
“NS1 can detect Dengue before D5 fever. IgM/IgG for fever > D5.”
|
Available | 21 |
“Available in our clinic.”
“This is usually what’s available at our lab.”
|
Good/Useful | 16 |
“Best thing since sliced bread”
“Useful as a good screening tool when Dengue fever is suspected”
|
Free | 15 |
“Free test via EHI diagnosis”
|
Standard test | 14 |
“Standard protocol.”
“Standard test at commercial lab used.”
|
Rapid result | 10 |
“I love using it. Gives rapid diagnosis on Dengue fever suspect”
|
Accurate result | 5 |
“Dengue duo- quite happy with it so far accurate.”
|
Easy to use | 5 |
“Using it seems simple enough.”
|
Diagnosis in early phase of fever | 2 |
“Very useful for early identification of cases so patients are more likely to agree to do daily blood for monitoring.”
|
Patient’s positive opinion | 2 |
“Patients really appreciate a quick diagnosis.”
|
Cost-effective | 1 |
“I find it useful, fast selective and cost effective.”
|
Negative | ||
Concern about cost | 9 |
“Given free so used it for trial otherwise expensive”
|
Concern about accuracy | 7 |
“After doing 3 cases on suspected Dengue- had 2 false negative- not found!”
|
Troublesome to use | 2 |
“Cumbersome / troublesome to use.”
|
Trust | 2 |
“I only use it at night or Sunday... Still trust the lab test for Dengue more than portable kit.”
|
Other test also used | 2 |
“Has to supplemented by FBC sent to the lab to have haematocrit/platelet.”
|
Not had occasion to use it much | 2 |
“[used] very little [so] not enough suspected cases seen.”
|
Only used when instructed to | 1 |
“Have used it during referral to a study in our clinic. But now stopped.”
|
Lack of official evaluation of it’s efficacy | 1 |
“Lack of official reports.”
|
Patient’s negative opinion | 1 |
“Patients are still new to the idea of a rapid test kit.”
|